[
  {
    "title": "Behind the science US editionCompanyCompanyPurpose, strategy and cultureRespiratory, immunology and inflammationOncologyOncologyMyelofibrosisOvarian c",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Behind the science US edition",
    "link": "https://us.gsk.com/en-us/behind-the-science-us-edition/",
    "timestamp": "unknown"
  },
  {
    "title": "CompanyCompanyPurpose, strategy and cultureRespiratory, immunology and inflammationOncologyOncologyMyelofibrosisOvarian cancerEndometrial cancerMultip",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Company",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Purpose, strategy and culture",
    "link": "https://us.gsk.com/en-us/company/purpose-strategy-and-culture/",
    "timestamp": "unknown"
  },
  {
    "title": "Respiratory, immunology and inflammation",
    "link": "https://us.gsk.com/en-us/company/respiratory-immunology-and-inflammation/",
    "timestamp": "unknown"
  },
  {
    "title": "OncologyOncologyMyelofibrosisOvarian cancerEndometrial cancerMultiple myeloma",
    "link": "https://us.gsk.com/en-us/company/oncology/",
    "timestamp": "unknown"
  },
  {
    "title": "Oncology",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Myelofibrosis",
    "link": "https://us.gsk.com/en-us/company/oncology/myelofibrosis/",
    "timestamp": "unknown"
  },
  {
    "title": "Ovarian cancer",
    "link": "https://us.gsk.com/en-us/company/oncology/ovarian-cancer/",
    "timestamp": "unknown"
  },
  {
    "title": "Endometrial cancer",
    "link": "https://us.gsk.com/en-us/company/oncology/endometrial-cancer/",
    "timestamp": "unknown"
  },
  {
    "title": "Multiple myeloma",
    "link": "https://us.gsk.com/en-us/company/oncology/multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "HIV",
    "link": "https://us.gsk.com/en-us/company/hiv/",
    "timestamp": "unknown"
  },
  {
    "title": "Infectious diseasesInfectious diseasesVaccinesFluRSV (Respiratory Syncytial Virus)Meningitis",
    "link": "https://us.gsk.com/en-us/company/infectious-diseases/",
    "timestamp": "unknown"
  },
  {
    "title": "Infectious diseases",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Vaccines",
    "link": "https://us.gsk.com/en-us/company/infectious-diseases/vaccines/",
    "timestamp": "unknown"
  },
  {
    "title": "Flu",
    "link": "https://us.gsk.com/en-us/company/infectious-diseases/flu/",
    "timestamp": "unknown"
  },
  {
    "title": "RSV (Respiratory Syncytial Virus)",
    "link": "https://us.gsk.com/en-us/company/infectious-diseases/rsv-respiratory-syncytial-virus/",
    "timestamp": "unknown"
  },
  {
    "title": "Meningitis",
    "link": "https://us.gsk.com/en-us/company/infectious-diseases/meningitis/",
    "timestamp": "unknown"
  },
  {
    "title": "InnovationInnovationTherapeutic areasTechnologiesClinical studiesClinical studiesRepresentative clinical trials",
    "link": "https://us.gsk.com/en-us/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Innovation",
    "link": "https://us.gsk.com/en-us/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Therapeutic areas",
    "link": "https://us.gsk.com/en-us/innovation/therapeutic-areas/",
    "timestamp": "unknown"
  },
  {
    "title": "Technologies",
    "link": "https://us.gsk.com/en-us/innovation/technologies/",
    "timestamp": "unknown"
  },
  {
    "title": "Clinical studiesClinical studiesRepresentative clinical trials",
    "link": "https://us.gsk.com/en-us/innovation/clinical-studies/",
    "timestamp": "unknown"
  },
  {
    "title": "Clinical studies",
    "link": "https://us.gsk.com/en-us/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Representative clinical trials",
    "link": "https://us.gsk.com/en-us/innovation/clinical-studies/representative-clinical-trials/",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://us.gsk.com/en-us/products/",
    "timestamp": "unknown"
  },
  {
    "title": "ResponsibilityResponsibilityInclusionUS charitable investmentsUS charitable investmentsCharitable grantsEthical standards",
    "link": "https://us.gsk.com/en-us/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Responsibility",
    "link": "https://us.gsk.com/en-us/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Inclusion",
    "link": "https://us.gsk.com/en-us/responsibility/inclusion/",
    "timestamp": "unknown"
  },
  {
    "title": "US charitable investmentsUS charitable investmentsCharitable grants",
    "link": "https://us.gsk.com/en-us/responsibility/us-charitable-investments/",
    "timestamp": "unknown"
  },
  {
    "title": "US charitable investments",
    "link": "https://us.gsk.com/en-us/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Charitable grants",
    "link": "https://us.gsk.com/en-us/responsibility/us-charitable-investments/charitable-grants/",
    "timestamp": "unknown"
  },
  {
    "title": "Ethical standards",
    "link": "https://us.gsk.com/en-us/responsibility/ethical-standards/",
    "timestamp": "unknown"
  },
  {
    "title": "MediaMediaPress releasesMedia contactsIn FocusIn FocusFlu is a Family AffairMapping MyelofibrosisFive for Five",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releases",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Media contacts",
    "link": "https://us.gsk.com/en-us/media/media-contacts/",
    "timestamp": "unknown"
  },
  {
    "title": "In FocusIn FocusFlu is a Family AffairMapping MyelofibrosisFive for Five",
    "link": "https://us.gsk.com/en-us/media/in-focus/",
    "timestamp": "unknown"
  },
  {
    "title": "In Focus",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Flu is a Family Affair",
    "link": "https://us.gsk.com/en-us/media/in-focus/flu-is-a-family-affair/",
    "timestamp": "unknown"
  },
  {
    "title": "Mapping Myelofibrosis",
    "link": "https://us.gsk.com/en-us/media/in-focus/mapping-myelofibrosis/",
    "timestamp": "unknown"
  },
  {
    "title": "Five for Five",
    "link": "https://us.gsk.com/en-us/media/in-focus/five-for-five/",
    "timestamp": "unknown"
  },
  {
    "title": "CareersCareersSearch jobsLife at GSKLife at GSKEmployment rights under federal lawExperienced professionalsExperienced professionalsA career in oncolo",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Search jobs",
    "link": "https://us.gsk.com/en-us/careers/search-jobs/",
    "timestamp": "unknown"
  },
  {
    "title": "Life at GSKLife at GSKEmployment rights under federal law",
    "link": "https://us.gsk.com/en-us/careers/life-at-gsk/",
    "timestamp": "unknown"
  },
  {
    "title": "Life at GSK",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Employment rights under federal law",
    "link": "https://us.gsk.com/en-us/careers/life-at-gsk/employment-rights-under-federal-law/",
    "timestamp": "unknown"
  },
  {
    "title": "Experienced professionalsExperienced professionalsA career in oncologyA career in Boston",
    "link": "https://us.gsk.com/en-us/careers/experienced-professionals/",
    "timestamp": "unknown"
  },
  {
    "title": "Experienced professionals",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "A career in oncology",
    "link": "https://us.gsk.com/en-us/careers/experienced-professionals/a-career-in-oncology/",
    "timestamp": "unknown"
  },
  {
    "title": "A career in Boston",
    "link": "https://us.gsk.com/en-us/careers/experienced-professionals/a-career-in-boston/",
    "timestamp": "unknown"
  },
  {
    "title": "Early careersEarly careersApprenticesInternships and co-opsScientific leadership programCommercial development program",
    "link": "https://us.gsk.com/en-us/careers/early-careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Early careers",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Apprentices",
    "link": "https://us.gsk.com/en-us/careers/early-careers/apprentices/",
    "timestamp": "unknown"
  },
  {
    "title": "Internships and co-ops",
    "link": "https://us.gsk.com/en-us/careers/early-careers/internships-and-co-ops/",
    "timestamp": "unknown"
  },
  {
    "title": "Scientific leadership program",
    "link": "https://us.gsk.com/en-us/careers/early-careers/scientific-leadership-program/",
    "timestamp": "unknown"
  },
  {
    "title": "Commercial development program",
    "link": "https://us.gsk.com/en-us/careers/early-careers/commercial-development-program/",
    "timestamp": "unknown"
  },
  {
    "title": "Veterans at GSK",
    "link": "https://us.gsk.com/en-us/careers/veterans-at-gsk/",
    "timestamp": "unknown"
  },
  {
    "title": "Dark ModeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Dark ModeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionalsHealthcare professionals",
    "link": "https://gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "Contact usContact us",
    "link": "https://us.gsk.com/en-us/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK HomepageSearchMenu",
    "link": "https://us.gsk.com/en-us/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Homepage",
    "link": "https://us.gsk.com/en-us/",
    "timestamp": "unknown"
  },
  {
    "title": "SearchMenu",
    "link": "https://us.gsk.com/en-us/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "United States (EN)Change locationGlobalDark ModeSwitch to dark mode to head towards a more sustainable world together.More infoHealthcare professional",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Change location",
    "link": "https://us.gsk.com/en-us/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Global",
    "link": "https://www.gsk.com",
    "timestamp": "unknown"
  },
  {
    "title": "Dark ModeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Dark ModeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionalsHealthcare professionals",
    "link": "https://gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "Contact usContact us",
    "link": "https://us.gsk.com/en-us/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Search",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Homepage",
    "link": "https://us.gsk.com/en-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Behind the science US edition",
    "link": "https://us.gsk.com/en-us/behind-the-science-us-edition/",
    "timestamp": "unknown"
  },
  {
    "title": "Company",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Innovation",
    "link": "https://us.gsk.com/en-us/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://us.gsk.com/en-us/products/",
    "timestamp": "unknown"
  },
  {
    "title": "Responsibility",
    "link": "https://us.gsk.com/en-us/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeMediaPress releases",
    "link": "https://us.gsk.com/en-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Home",
    "link": "https://us.gsk.com/en-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releases",
    "link": "https://us.gsk.com/en-us/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releasesBrowse US-specific press releases here.Please visit our Global websitefor access to global press releases dating back to 2009.Date range",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releasesBrowse US-specific press releases here.Please visit our Global websitefor access to global press releases dating back to 2009.",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releasesBrowse US-specific press releases here.Please visit our Global websitefor access to global press releases dating back to 2009.",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Browse US-specific press releases here.Please visit our Global websitefor access to global press releases dating back to 2009.",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Please visit our Global websitefor access to global press releases dating back to 2009.",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Date rangeSearchDate rangeMost recentJuly 24 2025GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-sponsors-2025-national-senior-games-as-part-of-sideline-rsv-campaign-to-raise-awareness-of-rsv-in-older-adults/",
    "timestamp": "unknown"
  },
  {
    "title": "Date rangeSearchDate rangeMost recentJuly 24 2025GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-sponsors-2025-national-senior-games-as-part-of-sideline-rsv-campaign-to-raise-awareness-of-rsv-in-older-adults/",
    "timestamp": "unknown"
  },
  {
    "title": "July 24 2025GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adultsNational TV special \u201cRed",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-sponsors-2025-national-senior-games-as-part-of-sideline-rsv-campaign-to-raise-awareness-of-rsv-in-older-adults/",
    "timestamp": "unknown"
  },
  {
    "title": "July 24 2025GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adultsNational TV special \u201cRed",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-sponsors-2025-national-senior-games-as-part-of-sideline-rsv-campaign-to-raise-awareness-of-rsv-in-older-adults/",
    "timestamp": "unknown"
  },
  {
    "title": "July 23 2025GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory mu",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-announces-extension-of-us-food-and-drug-administration-review-period-for-blenrep-belantamab-mafodotin-blmf-in-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "July 17 2025GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/ref",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-provides-update-on-us-fda-advisory-committee-review-of-blenrep-belantamab-mafodotin-blmf-combinations-for-patients-with-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "July 17 2025US FDA approves GSK\u2019s SHINGRIX in a prefilled syringe presentationPrefilled syringe presentation offers a convenient administration option",
    "link": "https://us.gsk.com/en-us/media/press-releases/us-fda-approves-gsk-s-shingrix-in-a-prefilled-syringe-presentation/",
    "timestamp": "unknown"
  },
  {
    "title": "July 14 2025US FDA accepts application to review expanded use of GSK\u2019s RSV vaccine, Arexvy, for adults 18-49 at increased riskSubmission supported by ",
    "link": "https://us.gsk.com/en-us/media/press-releases/fda-accepts-application-to-review-expanded-use-of-gsk-s-rsv-vaccine-arexvy/",
    "timestamp": "unknown"
  },
  {
    "title": "July 10 2025GSK begins shipping influenza vaccine doses for the 2025-26 flu seasonGSK has begun shipping trivalent flu vaccine doses to US healthcare ",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-begins-shipping-influenza-vaccine-doses-for-the-2025-26-flu-season/",
    "timestamp": "unknown"
  },
  {
    "title": "June 24 2025FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritisPediatric patients aged five years and older with a",
    "link": "https://us.gsk.com/en-us/media/press-releases/fda-approves-benlysta-belimumab-autoinjector-for-children-with-active-lupus-nephritis/",
    "timestamp": "unknown"
  },
  {
    "title": "June 18 2025Students step into the role of athletic trainers, cardiologists, dietitians, and more with free summer science programGSK Science in the S",
    "link": "https://us.gsk.com/en-us/media/press-releases/students-step-into-the-role-of-athletic-trainers-cardiologists-dietitians-and-more-with-free-summer-science-program/",
    "timestamp": "unknown"
  },
  {
    "title": "June 16 2025GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the USGrant funding will be provided ",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-announces-the-linked-by-lupus-optimal-care-initiative-to-help-support-individuals-with-lupus-in-the-us/",
    "timestamp": "unknown"
  },
  {
    "title": "June 04 2025GSK invests $450,000 in STEM education in Philadelphia public schoolsGlobal biopharma company GSK has donated $450,000 to STEM education i",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-invests-450-000-in-stem-education-in-philadelphia-public-schools/",
    "timestamp": "unknown"
  },
  {
    "title": "May 29 2025GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolioLatest data on belantamab mafodotin combinati",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-data-at-asco-and-eha-showcase-latest-research-and-innovation-across-the-oncology-portfolio/",
    "timestamp": "unknown"
  },
  {
    "title": "May 22 2025Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)Nucala is the only approved biol",
    "link": "https://us.gsk.com/en-us/media/press-releases/nucala-mepolizumab-approved-by-us-fda-for-use-in-adults-with-chronic-obstructive-pulmonary-disease-copd/",
    "timestamp": "unknown"
  },
  {
    "title": "May 14 2025GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liv",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty-medicine-to-treat-and-prevent-progression-of-steatotic-liver-disease-sld/",
    "timestamp": "unknown"
  },
  {
    "title": "May 09 2025GSK and Lifetime\u00ae launch original movie to raise awareness about the impact of meningitisPretty Hurts, a new Lifetime Original Movie brough",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-and-lifetime-launch-original-movie-to-raise-awareness-about-the-impact-of-meningitis/",
    "timestamp": "unknown"
  },
  {
    "title": "April 16 2025AREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee ",
    "link": "https://us.gsk.com/en-us/media/press-releases/arexvy-recommended-for-adults-aged-50-59-at-increased-risk-for-severe-respiratory-syncytial-virus-rsv-disease-by-us-advisory-committee-on-immunization-practices/",
    "timestamp": "unknown"
  },
  {
    "title": "April 16 2025GSK\u2019s 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization PracticesVaccine ",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-s-5-in-1-meningococcal-vaccine-penmenvy-receives-positive-recommendation-from-us-advisory-committee-on-immunization-practices/",
    "timestamp": "unknown"
  },
  {
    "title": "April 09 2025GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025GSK is funding public health or",
    "link": "https://us.gsk.com/en-us/media/press-releases/gsk-awards-2m-in-grant-funding-for-programs-supporting-adult-vaccination-commits-additional-2m-for-2025/",
    "timestamp": "unknown"
  },
  {
    "title": "March 25 2025Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and pediatric p",
    "link": "https://us.gsk.com/en-us/media/press-releases/blujepa-gepotidacin-approved-by-us-fda-for-treatment-of-uncomplicated-urinary-tract-infections-uutis-in-female-adults-and-pediatric-patients-12-years-of-age-and-older/",
    "timestamp": "unknown"
  },
  {
    "title": "March 12 2025ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved",
    "link": "https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-announces-new-implementation-study-data-showing-zero-cases-of-hiv-with-apretude/",
    "timestamp": "unknown"
  },
  {
    "title": "March 12 2025ViiV Healthcare\u2019s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatmen",
    "link": "https://us.gsk.com/en-us/media/press-releases/viiv-healthcare-s-investigational-broadly-neutralising-antibody-n6ls-successfully-maintains-viral-suppression-in-long-acting-treatment-of-hiv/",
    "timestamp": "unknown"
  },
  {
    "title": "Continue toMedia",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Continue toMedia",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Continue toMedia",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk Logo (1)This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.\u00a9 2001-2025 GSK",
    "link": "https://us.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk Logo (1)This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.\u00a9 2001-2025 GSK",
    "link": "https://us.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk Logo (1)This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.\u00a9 2001-2025 GSK",
    "link": "https://us.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk Logo (1)This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.\u00a9 2001-2025 GSK",
    "link": "https://us.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.\u00a9 2001-2025 GSK plc. All ri",
    "link": "https://us.gsk.com/en-us/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "This is our US website, intended for US audiences only. Other market sites can be reached by visiting ourlocation selector.",
    "link": "https://us.gsk.com/en-us/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK websitesGSK Global websiteLocations selectorGlobal Behind the scienceGSKPro for HCPsViiV HealthcareGSK study registerBusiness to BusinessQuick lin",
    "link": "https://www.gsk.com",
    "timestamp": "unknown"
  },
  {
    "title": "GSK websitesGSK Global websiteLocations selectorGlobal Behind the scienceGSKPro for HCPsViiV HealthcareGSK study registerBusiness to Business",
    "link": "https://www.gsk.com",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Global website",
    "link": "https://www.gsk.com",
    "timestamp": "unknown"
  },
  {
    "title": "Locations selector",
    "link": "https://us.gsk.com/en-us/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Global Behind the science",
    "link": "https://www.gsk.com/en-gb/behind-the-science/",
    "timestamp": "unknown"
  },
  {
    "title": "GSKPro for HCPs",
    "link": "https://gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "ViiV Healthcare",
    "link": "https://viivhealthcare.com/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK study register",
    "link": "https://www.gsk-studyregister.com/en/",
    "timestamp": "unknown"
  },
  {
    "title": "Business to Business",
    "link": "https://us.gsk.com/en-us/business-to-business-in-the-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Quick linksBehind the science US editionCompanyInnovationProductsResponsibilityMediaCareers",
    "link": "https://us.gsk.com/en-us/behind-the-science-us-edition/",
    "timestamp": "unknown"
  },
  {
    "title": "Behind the science US edition",
    "link": "https://us.gsk.com/en-us/behind-the-science-us-edition/",
    "timestamp": "unknown"
  },
  {
    "title": "Company",
    "link": "https://us.gsk.com/en-us/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Innovation",
    "link": "https://us.gsk.com/en-us/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://us.gsk.com/en-us/products/",
    "timestamp": "unknown"
  },
  {
    "title": "Responsibility",
    "link": "https://us.gsk.com/en-us/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://us.gsk.com/en-us/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://us.gsk.com/en-us/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Global investorsShareholdersQuarterly resultsFinancial reportsShare price analysisProduct pipeline",
    "link": "https://www.gsk.com/en-gb/investors/",
    "timestamp": "unknown"
  },
  {
    "title": "Shareholders",
    "link": "https://www.gsk.com/en-gb/investors/",
    "timestamp": "unknown"
  },
  {
    "title": "Quarterly results",
    "link": "https://www.gsk.com/en-gb/investors/quarterly-results/",
    "timestamp": "unknown"
  },
  {
    "title": "Financial reports",
    "link": "https://www.gsk.com/en-gb/investors/financial-reports/",
    "timestamp": "unknown"
  },
  {
    "title": "Share price analysis",
    "link": "https://www.gsk.com/en-gb/investors/dividend-and-share-price/",
    "timestamp": "unknown"
  },
  {
    "title": "Product pipeline",
    "link": "https://www.gsk.com/en-gb/innovation/pipeline/",
    "timestamp": "unknown"
  },
  {
    "title": "Get in touchContact usReport a possible side effectGSK Speak upFollow us on:",
    "link": "https://us.gsk.com/en-us/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Contact us",
    "link": "https://us.gsk.com/en-us/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Report a possible side effect",
    "link": "https://us.gsk.com/en-us/report-a-possible-side-effect/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Speak up",
    "link": "https://www.gsk.com/speakup",
    "timestamp": "unknown"
  },
  {
    "title": "Follow us on:",
    "link": "https://www.facebook.com/GSK",
    "timestamp": "unknown"
  },
  {
    "title": "Accessibility",
    "link": "https://us.gsk.com/en-us/accessibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Digital sustainability",
    "link": "https://us.gsk.com/en-us/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Terms of use",
    "link": "https://us.gsk.com/en-us/terms-of-use/",
    "timestamp": "unknown"
  },
  {
    "title": "Privacy notice",
    "link": "https://privacy.gsk.com/en-us/privacy-notice/",
    "timestamp": "unknown"
  },
  {
    "title": "Sitemap",
    "link": "https://us.gsk.com/en-us/sitemap/",
    "timestamp": "unknown"
  },
  {
    "title": "_",
    "link": "https://us.gsk.com/en-us/media/press-releases/?CacheTarget=NULL",
    "timestamp": "unknown"
  }
]rk mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionalsHealthcare professionals",
    "link": "https://www.gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "Contact usContact us",
    "link": "https://www.gsk.com/en-gb/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK HomepageChange locationSearchMenu",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Homepage",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Change locationSearchMenu",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "GlobalChange locationDark modeSwitch to dark mode to head towards a more sustainable world together.More infoHealthcare professionalsHealthcare profes",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Change location",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Dark modeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Dark modeSwitch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Switch to dark mode to head towards a more sustainable world together.More info",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Healthcare professionalsHealthcare professionals",
    "link": "https://www.gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "Contact usContact us",
    "link": "https://www.gsk.com/en-gb/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Search",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Homepage",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Behind the science magazine",
    "link": "https://www.gsk.com/en-gb/behind-the-science-magazine/",
    "timestamp": "unknown"
  },
  {
    "title": "Company",
    "link": "https://www.gsk.com/en-gb/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Innovation",
    "link": "https://www.gsk.com/en-gb/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://www.gsk.com/en-gb/products/",
    "timestamp": "unknown"
  },
  {
    "title": "Responsibility",
    "link": "https://www.gsk.com/en-gb/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Investors",
    "link": "https://www.gsk.com/en-gb/investors/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://www.gsk.com/en-gb/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://www.gsk.com/en-gb/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "HomeMediaPress release archive",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Home",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://www.gsk.com/en-gb/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Press release archive",
    "link": "https://www.gsk.com/en-gb/media/press-releases/",
    "timestamp": "unknown"
  },
  {
    "title": "Press release archiveBrowse GSK's global press release archive for media and investors.\u00a0 Search by keyword or browse by year/business category.Press r",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Press release archiveBrowse GSK's global press release archive for media and investors.\u00a0 Search by keyword or browse by year/business category.Press r",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Press release archiveBrowse GSK's global press release archive for media and investors.\u00a0 Search by keyword or browse by year/business category.Press r",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Browse GSK's global press release archive for media and investors.\u00a0 Search by keyword or browse by year/business category.Press releases issued by our",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Press releases issued by our local operating companies can be viewed on ourmarket websites.",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Select date rangeSearchDate rangeMost recent24 July 2025Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractor",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-eu-for-treatment-of-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "Select date rangeSearchDate rangeMost recent24 July 2025Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractor",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-eu-for-treatment-of-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "24 July 2025Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractory multiple myelomaSixth regulatory approval ",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-eu-for-treatment-of-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "24 July 2025Blenrep (belantamab mafodotin) combinations approved in EU for treatment of relapsed/refractory multiple myelomaSixth regulatory approval ",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-eu-for-treatment-of-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "23 July 2025GSK announces extension of US Food and Drug Administration review period for Blenrep (belantamab mafodotin-blmf) in relapsed/refractory mu",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-announces-extension-of-us-food-and-drug-administration-review-period-for-blenrep-belantamab-mafodotin-blmf-in-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "17 July 2025GSK provides update on US FDA advisory committee review of Blenrep (belantamab mafodotin-blmf) combinations for patients with relapsed/ref",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-provides-update-on-us-fda-advisory-committee-review-of-blenrep-belantamab-mafodotin-blmf-combinations-for-patients-with-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "17 July 2025US FDA approves GSK\u2019s Shingrix in a prefilled syringe presentationPrefilled syringe presentation offers a convenient administration option",
    "link": "https://www.gsk.com/en-gb/media/press-releases/us-fda-approves-gsk-s-shingrix-in-a-prefilled-syringe-presentation/",
    "timestamp": "unknown"
  },
  {
    "title": "14 July 2025ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV",
    "link": "https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-extends-voluntary-licensing-agreement-with-medicines-patent-pool-to-enable-access-to-innovative-long-acting-injectable-hiv-treatment/",
    "timestamp": "unknown"
  },
  {
    "title": "14 July 2025ViiV Healthcare data show 89% of treatment-na\u00efve people with HIV choose to switch to long-acting injectable Vocabria + Rekambys from daily",
    "link": "https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-data-show-89-of-treatment-naive-people-with-hiv-choose-to-switch-to-long-acting-injectable-vocabria-plus-rekambys-from-daily-pills-after-achieving-rapid-viral-suppression/",
    "timestamp": "unknown"
  },
  {
    "title": "14 July 2025US FDA accepts application to review expanded use of GSK\u2019s RSV vaccine, Arexvy, for adults 18-49 at increased riskMore than 21 million US ",
    "link": "https://www.gsk.com/en-gb/media/press-releases/us-fda-accepts-application-to-review-expanded-use-of-gsk-s-rsv-vaccine/",
    "timestamp": "unknown"
  },
  {
    "title": "08 July 2025ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025Re",
    "link": "https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-presents-new-data-demonstrating-positive-real-world-impact-of-its-innovative-long-acting-injectables-for-hiv-at-ias-2025/",
    "timestamp": "unknown"
  },
  {
    "title": "07 July 2025GSK completes acquisition of efimosfermin, a potential best-in-class specialty medicine to treat and prevent progression of steatotic live",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-completes-acquisition-of-efimosfermin/",
    "timestamp": "unknown"
  },
  {
    "title": "25 June 2025Price of world\u2019s first malaria vaccine (RTS,S) for children in endemic countries to be reduced by more than half, to less than $5Price red",
    "link": "https://www.gsk.com/en-gb/media/press-releases/price-of-world-s-first-malaria-vaccine-rts-s-for-children-in-endemic-countries-to-be-reduced/",
    "timestamp": "unknown"
  },
  {
    "title": "23 June 2025Linerixibat accepted for review by the European Medicines Agency for cholestatic pruritus in patients with primary biliary cholangitis (PB",
    "link": "https://www.gsk.com/en-gb/media/press-releases/linerixibat-accepted-for-review-by-the-european-medicines-agency/",
    "timestamp": "unknown"
  },
  {
    "title": "20 June 2025Japan\u2019s Ministry of Health, Labour and Welfare accepts regulatory application to expand use of GSK\u2019s RSV vaccine, Arexvy, in adults aged 1",
    "link": "https://www.gsk.com/en-gb/media/press-releases/japan-s-ministry-of-health-labour-and-welfare-accepts-regulatory-application-to-expand-use-of-gsk-s-rsv-vaccine-arexvy/",
    "timestamp": "unknown"
  },
  {
    "title": "13 June 2025GSK\u2019s RSV vaccine, Arexvy, accepted for regulatory review by the European Medicines Agency to expand use in adults 18 years and olderRegul",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-s-rsv-vaccine-arexvy-accepted-for-regulatory-review-by-the-european-medicines-agency-to-expand-use-in-adults-18-years-and-older/",
    "timestamp": "unknown"
  },
  {
    "title": "12 June 2025GSK licenses Shigella vaccine candidate to Bharat Biotech for continued developmentGSK plc announced today that it has licensed its Shigel",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-licenses-shigella-vaccine-candidate-to-bharat-biotech-for-continued-development/",
    "timestamp": "unknown"
  },
  {
    "title": "02 June 2025Linerixibat New Drug Application (NDA) accepted for review by the US FDA for cholestatic pruritus in patients with primary biliary cholang",
    "link": "https://www.gsk.com/en-gb/media/press-releases/linerixibat-new-drug-application-nda-accepted-for-review-by-the-us-fda/",
    "timestamp": "unknown"
  },
  {
    "title": "29 May 2025GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolioGSK today announced that data across the onco",
    "link": "https://www.gsk.com/en-gb/media/press-releases/gsk-data-at-asco-and-eha-showcase-latest-research-and-innovation-across-the-oncology-portfolio/",
    "timestamp": "unknown"
  },
  {
    "title": "28 May 2025PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by Independent Data Monitoring CommitteeData to be p",
    "link": "https://www.gsk.com/en-gb/media/press-releases/pivot-po-phase-iii-study-for-tebipenem-hbr-stopped-early-for-efficacy-following-review-by-independent-data-monitoring-committee/",
    "timestamp": "unknown"
  },
  {
    "title": "23 May 2025Blenrep (belantamab mafodotin) combinations receive positive CHMP opinion in relapsed/refractory multiple myelomaPositive opinion supported",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-receive-positive-chmp-opinion-in-relapsedrefractory-multiple-myeloma/",
    "timestamp": "unknown"
  },
  {
    "title": "22 May 2025Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)Approval based on the positive M",
    "link": "https://www.gsk.com/en-gb/media/press-releases/nucala-mepolizumab-approved-by-us-fda/",
    "timestamp": "unknown"
  },
  {
    "title": "19 May 2025Blenrep (belantamab mafodotin) combinations approved in Japan for treatment of relapsed/refractory multiple myelomaSecond major approval fo",
    "link": "https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-japan/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk LogoThis is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visitin",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk LogoThis is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visitin",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk LogoThis is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visitin",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "Gsk LogoThis is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visitin",
    "link": "https://www.gsk.com/en-gb/",
    "timestamp": "unknown"
  },
  {
    "title": "This is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visiting ourloc",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "This is our global website, intended for visitors seeking information on GSK's worldwide business.\u00a0 Our market sites can be reached by visiting ourloc",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "> Modern Slavery Act Statement 2024(PDF - 162.5KB)",
    "link": "https://www.gsk.com/media/d5abb1vg/modern-slavery-act-statement-2024.pdf",
    "timestamp": "unknown"
  },
  {
    "title": "GSK websitesLocations selectorSocial media directoryGSKPro for healthcare professionalsGSK study registerSupplier websiteViiV HealthcareQuick linksBeh",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK websitesLocations selectorSocial media directoryGSKPro for healthcare professionalsGSK study registerSupplier websiteViiV Healthcare",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Locations selector",
    "link": "https://www.gsk.com/en-gb/locations/",
    "timestamp": "unknown"
  },
  {
    "title": "Social media directory",
    "link": "https://www.gsk.com/en-gb/media/social-media/",
    "timestamp": "unknown"
  },
  {
    "title": "GSKPro for healthcare professionals",
    "link": "https://www.gskpro.com",
    "timestamp": "unknown"
  },
  {
    "title": "GSK study register",
    "link": "https://www.gsk-studyregister.com/en/",
    "timestamp": "unknown"
  },
  {
    "title": "Supplier website",
    "link": "https://supplier.gsk.com",
    "timestamp": "unknown"
  },
  {
    "title": "ViiV Healthcare",
    "link": "https://viivhealthcare.com/",
    "timestamp": "unknown"
  },
  {
    "title": "Quick linksBehind the science magazineCompanyInnovationProductsResponsibilityInvestorsMediaCareers",
    "link": "https://www.gsk.com/en-gb/behind-the-science-magazine/",
    "timestamp": "unknown"
  },
  {
    "title": "Behind the science magazine",
    "link": "https://www.gsk.com/en-gb/behind-the-science-magazine/",
    "timestamp": "unknown"
  },
  {
    "title": "Company",
    "link": "https://www.gsk.com/en-gb/company/",
    "timestamp": "unknown"
  },
  {
    "title": "Innovation",
    "link": "https://www.gsk.com/en-gb/innovation/",
    "timestamp": "unknown"
  },
  {
    "title": "Products",
    "link": "https://www.gsk.com/en-gb/products/",
    "timestamp": "unknown"
  },
  {
    "title": "Responsibility",
    "link": "https://www.gsk.com/en-gb/responsibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Investors",
    "link": "https://www.gsk.com/en-gb/investors/",
    "timestamp": "unknown"
  },
  {
    "title": "Media",
    "link": "https://www.gsk.com/en-gb/media/",
    "timestamp": "unknown"
  },
  {
    "title": "Careers",
    "link": "https://www.gsk.com/en-gb/careers/",
    "timestamp": "unknown"
  },
  {
    "title": "Get in touchContact usPartnershipsReport a possible side effectGSK Speak upFollow us on:",
    "link": "https://www.gsk.com/en-gb/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Contact us",
    "link": "https://www.gsk.com/en-gb/contact-us/",
    "timestamp": "unknown"
  },
  {
    "title": "Partnerships",
    "link": "https://www.gsk.com/en-gb/innovation/partnerships/",
    "timestamp": "unknown"
  },
  {
    "title": "Report a possible side effect",
    "link": "https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/",
    "timestamp": "unknown"
  },
  {
    "title": "GSK Speak up",
    "link": "https://www.gsk.com/speakup",
    "timestamp": "unknown"
  },
  {
    "title": "Follow us on:",
    "link": "https://www.facebook.com/GSK",
    "timestamp": "unknown"
  },
  {
    "title": "Accessibility",
    "link": "https://www.gsk.com/en-gb/accessibility/",
    "timestamp": "unknown"
  },
  {
    "title": "Digital sustainability",
    "link": "https://www.gsk.com/en-gb/digital-sustainability/",
    "timestamp": "unknown"
  },
  {
    "title": "Terms of use",
    "link": "https://www.gsk.com/en-gb/terms-of-use/",
    "timestamp": "unknown"
  },
  {
    "title": "Privacy notice",
    "link": "https://privacy.gsk.com/en-gb/privacy-notice/general",
    "timestamp": "unknown"
  },
  {
    "title": "Sitemap",
    "link": "https://www.gsk.com/en-gb/sitemap/",
    "timestamp": "unknown"
  },
  {
    "title": "_",
    "link": "https://www.gsk.com/en-gb/media/press-releases/?CacheTarget=NULL",
    "timestamp": "unknown"
  }
]